Return to program book search
Pearls from the Posters: New and Noteworthy Research Finds
Saturday, March 22
7:15 AM - 8:45 AM
Lorraine L. Rosamilia, MD, FAAD
Following this course, the attendee should be able to:
- Analyze new therapeutics in the pipeline and methods of predicting response to treatment.
- Evaluate associations that suggest evaluation for coexistent disease.
7805 - Erythroderma: Searching for diagnostic clues in a series of 164 patients
7885 - Interleukin 33 is differentially expressed in psoriasis-like drug reactions to TNF antagonists
8324 - Melanoma associated with TNFa inhibitors: A research on adverse drug reactions (RADAR) report
8398 - Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-alpha inhibitors versus methotrexate
7571 - Immunohistochemical detection of BRAF mutation in melanoma
7622 - A population-based study on the association between bullous pemphigoid and neurologic disease
7657 - Number needed to treat and cost per responder for biologic therapies for the treatment of moderate to severe psoriasis
8033 - Secukinumab efficacy in subjects with moderate-to-severe plaque psoriasis and concomitant psoriatic arthritis: A subanalysis of the ERASURE study